Share Option Plans - The total number of shares available for issuance under the 2013 share option plan is 599,889,841 shares, accounting for approximately 9.9% of the company's issued share capital as of December 31, 2024[4]. - The 2013 share option plan has expired on May 23, 2023, and no further options can be granted under this plan[4]. - The company disclosed that there were no new options granted during the year[8]. - The company has a total of 30,000,000 options granted in 2016 at an exercise price of HKD 0.53 per share, expiring on January 28, 2017[8]. - The company has a total of 10,000,000 options that were not exercised in 2016, which have now expired[8]. - The company has provided additional information regarding the 2013 share option plan in accordance with listing rules[3]. - The total stock options granted in 2024 amounted to 258,000,000 shares, with 22,000,000 shares expiring, resulting in a net total of 236,000,000 shares available[10]. - The total stock options granted in 2015 were 52,500,000, with 43,500,000 granted in 2016, reflecting a consistent approach to employee incentives[10]. Exercise and Expiration of Options - The exercise price for the options granted in 2015 is HKD 0.61 per share, with a total of 20,000,000 options available for exercise until April 1, 2025[8]. - The company has not exercised any options during the year, with a total of 15,000,000 options remaining unexercised as of December 31, 2024[8]. - The exercise price for the stock options granted in 2016 is set at HKD 0.61 per share, while the options granted in 2017 have an exercise price of HKD 0.53[10]. - The stock options are valid for exercise until April 1, 2025, for the first batch and until January 27, 2026, for the second batch[14]. - The total number of stock options exercised in the year was zero, indicating no dilution of shares from exercised options[10]. Governance Structure - The company’s board of directors includes five executive directors and four independent non-executive directors, ensuring a diverse governance structure[13]. Employee Incentives - The company’s stock option plan is designed to align employee interests with shareholder value, promoting long-term growth[14]. - The first 30% of stock options granted in 2016 will vest starting from April 2, 2016, with subsequent tranches vesting in 2017 and 2018[14]. Financial Reporting - The company has not reported any changes to other financial data in the 2024 annual report aside from the disclosed stock options[11]. - The company’s board can decide to terminate the 2013 plan early based on its provisions[7]. - The 2013 plan was effective for ten years from its adoption date, which means it was valid until May 24, 2023[7].
北京健康(02389) - 2024 - 年度业绩